ADC Therapeutics SA Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
REDMILE GROUP, LLC | 02/14/2025 | 15.67 M | $31.18 M | -0.02% | 14.95% |
PROSIGHT MANAGEMENT, LP | 02/14/2025 | 9.52 M | $18.93 M | -1.26% | 9.08% |
ORBIMED ADVISORS LLC | 02/14/2025 | 5.97 M | $11.88 M | 31.64% | 5.69% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.01 M | $9.97 M | 13.93% | 4.78% |
WOODLINE PARTNERS LP | 02/14/2025 | 1.93 M | $3.85 M | 100.00% | 1.84% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.67 M | $3.33 M | -0.91% | 1.60% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 1.61 M | $3.21 M | 11.63% | 1.54% |
STATE STREET CORP | 02/14/2025 | 1.19 M | $2.36 M | 7.43% | 1.13% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 963,109 | $1.92 M | 1.04% | 0.92% |
UBS GROUP AG | 02/14/2025 | 884,518 | $1.76 M | 2,123.80% | 0.84% |
VANTAGE CONSULTING GROUP INC | 02/12/2025 | 850,737 | $1.69 M | 0.00% | 0.81% |
BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 733,568 | $1.46 M | 0.00% | 0.70% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 716,668 | $1.43 M | 100.00% | 0.68% |
VANGUARD GROUP INC | 02/11/2025 | 644,618 | $1.28 M | 19.52% | 0.61% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 411,124 | $818,137 | -42.29% | 0.39% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 253,342 | $504,150 | 50.30% | 0.24% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 224,081 | $445,921 | 9.80% | 0.21% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 194,258 | $386,573 | 0.00% | 0.19% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 183,231 | $364,630 | -25.29% | 0.17% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 171,993 | $342,265 | 6.01% | 0.16% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 152,047 | $302,574 | 17.81% | 0.15% |
BARCLAYS PLC | 02/13/2025 | 141,495 | $282,000 | 10.77% | 0.14% |
FMR LLC | 02/13/2025 | 127,019 | $252,768 | 139.47% | 0.12% |
SANIBEL CAPTIVA TRUST COMPANY, INC. | 01/15/2025 | 113,000 | $224,870 | 0.00% | 0.11% |
RHUMBLINE ADVISERS | 01/30/2025 | 110,037 | $218,963 | 15.60% | 0.11% |
SQUAREPOINT OPS LLC | 02/14/2025 | 107,231 | $213,390 | 42.23% | 0.10% |
BRYN MAWR TRUST CO | 01/28/2025 | 100,000 | $199,000 | 0.00% | 0.10% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 65,267 | $129,881 | 122.94% | 0.06% |
CITIGROUP INC | 02/12/2025 | 64,139 | $127,636 | 8.89% | 0.06% |
DEUTSCHE BANK AG\ | 02/14/2025 | 56,062 | $111,563 | 40.70% | 0.05% |
MAGNETAR FINANCIAL LLC | 02/11/2025 | 55,762 | $110,966 | 0.00% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 51,198 | $101,884 | 100.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 46,520 | $92,575 | 21.54% | 0.04% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 41,832 | $83,246 | 39.45% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 40,430 | $80,456 | -7.02% | 0.04% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 39,611 | $79,000 | -1.98% | 0.04% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 39,362 | $78,330 | 78.05% | 0.04% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 38,435 | $76,486 | 195.70% | 0.04% |
JPMORGAN CHASE & CO | 02/12/2025 | 37,021 | $73,671 | -53.03% | 0.04% |
INVESCO LTD. | 02/13/2025 | 34,369 | $68,395 | 5.20% | 0.03% |
METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 31,117 | $61,923 | -27.78% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 28,900 | $57,511 | 100.00% | 0.03% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 28,831 | $58,000 | 0.00% | 0.03% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 28,588 | $56,890 | 10.67% | 0.03% |
DLK INVESTMENT MANAGEMENT, LLC | 01/16/2025 | 25,805 | $51,352 | -22.17% | 0.02% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 23,786 | $47,334 | -6.35% | 0.02% |
SEI INVESTMENTS CO | 02/11/2025 | 22,989 | $45,748 | 100.00% | 0.02% |
PROSHARE ADVISORS LLC | 02/14/2025 | 22,901 | $45,573 | 49.04% | 0.02% |
02/11/2025 | 22,819 | $45,410 | 100.00% | 0.02% | |
SAXONY CAPITAL MANAGEMENT, LLC | 01/23/2025 | 22,288 | $44,353 | 0.22% | 0.02% |
ADC Therapeutics SA institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of ADC Therapeutics SA. The most heavily invested institutionals were:
Redmile Group, LLC: 15.67 M
Prosight Management, LP: 9.52 M
ORBIMED ADVISORS LLC: 5.97 M
BlackRock Funding, Inc. /DE: 5.01 M
Woodline Partners LP: 1.93 M
GOLDMAN SACHS GROUP INC: 1.67 M
53.89% of ADC Therapeutics SA stock is owned by institutional investors.
Institutional investors have bought a total of 63.17 M shares in the last 24 months. This purchase volume represents approximately $122.56 M in transactions.